.alpha.-glucosidase inhibitors
US5097023A · kind A · utility
10Cited by
1References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 1990 |
| Grant date | Mar 17, 1992 |
| Priority date | — |
| Expiry date | Sep 17, 2010 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H15/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to novel N-glycosyl derivatives of 1,4-dideoxy-1,4-imino-D-arabinitol, to the chemical processes for their preparation, to their .alpha.-glucosidase inhibiting properties, and to their end-use application in the treatment of diabetes, obesity and those diseases associated with retroviruses, particularly the HIV virus reported to be the causative of the acquired immune deficiency syndrome (AIDS).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.